An analysis of nuclear YAP/TAZ expression in hepatocellular carcinoma tissues revealed that in 70% of patient-derived samples, either YAP or TAZ, but not both, was predominantly localized in the nucleus29. This evidence concerns the gene YAP1 and hepatocellular carcinoma.